Analysis of allele-specific RNA transcription in FSHD by RNA-DNA FISH in single myonuclei

European Journal of Human Genetics

Volumn 18, Issue 4, 2010, Pages 448-456

  Masny, Peter S ^a,b   Chan, On Ying A ^c,d   De Greef, Jessica C ^c   Bengtsson, Ulla ^a   Ehrlich, Melanie ^e   Tawil, Rabi ^f   Lock, Leslie F ^a   Hewitt, Jane E ^g   Stocksdale, Jennifer ^a   Martin, Jorge H ^a   Van Der Maarel, Silvere M ^c   Winokur, Sara T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e TULANE UNIVERSITY   (United States)

^f UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^g UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Allelic expression; ANT1; Facioscapulohumeral muscular dystrophy; FRG1l; FSHD; RNA FISH

Indexed keywords

BLOOD CLOTTING FACTOR 11; CYTOCHROME P450 4V2; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY REGION GENE 1 PROTEIN; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY REGION GENE 2 PROTEIN; GENE PRODUCT; HEY LIKE TRANSCRIPTIONAL REPRESSOR PROTEIN; INHIBITOR OF GROWTH FAMILY 2 PROTEIN; INTERFERON REGULATORY FACTOR 2; KALLIKREIN; LRP2 BINDING PROTEIN; PDZ AND LIM DOMAIN 3 PROTEIN; PROTEIN FAT1; SORBIN AND SH3 DOMAIN CONTAINING 2 PROTEIN; SORTING NEXIN 25 PROTEIN; TOLL LIKE RECEPTOR 3; TUBULIN 4Q PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL NUCLEUS; CHROMOSOME 4Q; CONTROLLED STUDY; DNA RNA HYBRIDIZATION; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MUSCLE CELL; MYOTUBE; PRIORITY JOURNAL; RNA TRANSCRIPTION;

ALLELES; CELL NUCLEUS; CELLS, CULTURED; CHROMATIN; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 4; DNA; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MICROSCOPY, FLUORESCENCE; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; MYOBLASTS; RNA; TANDEM REPEAT SEQUENCES; TELOMERE; TRANSCRIPTION, GENETIC;

EID: 77949656794     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2009.183     Document Type: Article

References (43)

1. Tawil R, van der Maarel SM: Facioscapulohumeral muscular dystrophy. Muscle Nerve 2006; 34: 1-15.
2. van der Maarel SM, Frants RR: The D4Z4 repeat-mediated pathogenesis of faciosca-pulohumeral muscular dystrophy. Am J Hum Genet 2005; 76: 375-386.
3. Padberg GW, Adams C: Facioscapulohumeral muscular dystrophy; in: Pulst S-M (ed.): Neurogenetics. Oxford, UK: Oxford University Press, 2000. pp 105-116.
4. Padberg GW, Brouwer OF, de Keizer RJ et al: Retinal vascular disease and sensor-ineural deafness are part of facioscapulohumeral muscular dystrophy. Am J Hum Genet 1992; 51 (S): A104.
5. Funakoshi M, Goto K, Arahata K: Epilepsy and mental retardation in a subset of early onset 4q35-facioscapulohumeral muscular dystrophy. Neurology 1998; 50: 1791-1794.
6. Wijmenga C, Hewitt JE, Sandkuijl LA et al: Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat Genet 1992; 2: 26-30.
7. van Deutekom JC, Wijmenga C, van Tienhoven EA et al: FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. Hum Mol Genet 1993; 2: 2037-2042.
8. Clapp J, Mitchell LM, Bolland DJ: Evolutionary conservation of a coding function for D4Z4, the tandem DNA repeat mutated in facioscapulohumeral muscular dystrophy. Am J Hum Genet 2007; 81: 264-279.
9. Lemmers RJ, de Kievit P, Sandkuijl L et al: Facioscapulohumeral muscular dystrophy is uniquely associated with one of the two variants of the 4q subtelomere. Nat Genet 2002; 32: 235-236.
10. Lemmers RJ, Wohlgemuth M, van der Gaag KJ et al: Specific sequence variations within the 4q35 region are associated with facioscapulohumeral muscular dystrophy. Am J Hum Genet 2007; 81: 884-894.
11. Winokur ST, Bengtsson U, Feddersen J et al: The DNA rearrangement associated with facioscapulohumeral muscular dystrophy involves a heterochromatin-associated repetitive element: implications for a role of chromatin structure in the pathogenesis of the disease. Chromosome Res 1994; 2: 225-234.
12. Hewitt JE, Lyle R, Clark LN et al: Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy. Hum Mol Genet 1994; 3: 1287-1295.
13. Yang F, Shao C, Vedanarayanan V, Ehrlich M: Cytogenetic and immuno-FISH analysis of the 4q subtelomeric region, which is associated with facioscapulohumeral muscular dystrophy. Chromosoma 2004; 112: 350-359.
14. Snider L, Asawachaicharn A, Tyler AE et al: RNA transcripts, miRNA-sized fragments, and proteins produced from D4Z4 units. New candidates for the pathophysiology of facioscapulohumoral dystrophy. Hum Mol Genet 2009; 18: 2414-2430.
15. Masny PS, Bengtsson U, Chung SA. et al: Localization of 4q35.2 to the nuclear periphery: is FSHD a nuclear envelope disease? Hum Mol Genet 2004; 13: 1857-1871.
16. Tam R, Smith KP, Lawrence JB: The 4q subtelomere harboring the FSHD locus is specifically anchored with peripheral heterochromatin unlike most human telomeres. J Cell Biol 2004; 167: 269-279.
17. Rijkers T, Deidda G, van Koningsbruggen S et al: FRG2, an FSHD candidate gene, is transcriptionally upregulated in differentiating primary myoblast cultures of FSHD. J Med Genet 41: 826-836.
18. Feuk L, Marshall CR, Wintle RF, Scherer SW: Structural variants: changing the landscape of chromosomes and design of disease studies. Hum Mol Genet 2006; 15: R57-R66.
19. Gabellini D, Green MR, Tupler R: Inappropriate gene activation in FSHD: a repressor complex binds a chromosomal repeat deleted in dystrophic muscle. Cell 2002; 110: 339-348.
20. Jiang G, Yang F, van Overveld PG et al: Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q. Hum Mol Genet 2003; 12: 2909-2921.
21. Winokur ST, Chen YW, Masny PS et al: Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation. Hum Mol Genet 2003; 12: 2895-2907.
22. Osborne RJ, Welle S, Venance SL, Thornton CA, Tawil R: Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy. Neurology 2007; 68: 569-577.
23. Celegato B, Capitanio D, Pescatori M et al: Parallel protein and transcript profiles of FSHD patient muscles correlate to the D4Z4 arrangement and reveal a common impairment of slow to fast fibre differentiation and a general deregulation of MyoD-dependent genes. Proteomics 2006; 6: 5303-5321.
24. Klooster R, Straasheijm K, Shah B et al: Comprehensive expression analysis of FSHD candidate genes on mRNA and protein levels. Eur J Hum Genet 2009. This issue.
25. Herzing LB, Cook Jr EH, Ledbetter DH: Allele-specific expression analysis by RNA-FISH demonstrates preferential maternal expression of UBE3A and imprint maintenance within 15q11-q13 duplications. Hum Mol Genet 2002; 11: 1707-1718.
26. Tam R, Shopland LS, Johnson CV et al: Applications of RNA FISH for visualizing gene expression and nuclear architecture. In: Beatty BMSSJ (ed).: FISH Practical Approach. Volume 260 New York: Oxford University Press, 2002. pp 93-118.
27. van Raamsdonk CD, Tilghman SM: Optimizing the detection of nascent transcripts by RNA fluorescence in situ hybridization. Nucleic Acids Res 2001; 29: E42-E42.
28. Riess O, Siedlaczck I, Kredtke S, Melmer G, Epplen JT, Deaven LL: Characterization of a human chromosome 4 flow-sorted cosmid library. Cytogenet Cell Genet 1994; 65: 238-242.
29. Kohda A, Taguchi H, Okumura K: Visualization of biallelic expression of the imprinted SNRPN gene induced by inhibitors of DNA methylation and histone deacetylation. Biosci Biotechnol Biochem 2001; 5: 1236-1239.
30. Femino AM, Fay FS, Fogarty K, Singer RH: Visualization of single RNA transcripts in situ. Science 1998; 280: 585-590.
31. Gabellini D, D'Antona G, Moggio M et al: Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1. Nature 2006; 439: 973-977.
32. Myers TK, Andreuzza SE, Franklin DS: p18INK4c and p27KIP1 are required for cell cycle arrest of differentiated myotubes. Exp Cell Res 2004; 300: 365-378.
33. Smith KP, Moen PT, Wydner KL, Coleman JR, Lawrence JB: Processing of endogenous pre-mRNAs in association with SC-35 domains is gene specific. J Cell Biol 1999; 144: 617-629.
34. Nutt SL, Vambrie S, Steinlein P et al: Independent regulation of the two Pax5 alleles during B-cell development. Nat Genet 1999; 21: 390-395.
35. Beckers M, Gabriëls J, van der Maarel S et al: Active genes in junk DNA? Characterization of DUX genes embedded within 3.3 kb repeated elements. Gene 2001; 264: 51-57.
36. Dixit M, Ansseau E, Tassin A et al: DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1. Proc Natl Acad Sci USA 2007; 104: 18157-18162.
37. van Overveld PG, Lemmers RJ, Sandkuijl LA et al: Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy. Nat Genet 2003; 35: 315-317.
38. de Greef JC, Wohlgemuth M, Chan OA et al: Hypomethylation is restricted to the D4Z4 repeat array in phenotypic FSHD. Neurology 2007; 69: 1018-1026.
39. Zeng W, de Greef JC, Chen YY et al: Specific loss of histone H3 lysine 9 trimethylation and HP1g/cohesin binding at D4Z4 repeats is associated with facioscapulohumeral dystrophy (FSHD). PLoS 2009; 5: e1000559. in press.
40. Mongan NP, Martin KM, Gudas LJ: The putative human stem cell marker, Rex-1 (Zfp42): structural classification and expression in normal human epithelial and carcinoma cell cultures. Mol Carcinog 2006; 45: 887-900.
41. Kim J, Chu J, Shen X, Wang J, Orkin SH: An extended transcriptional network for pluripotency of embryonic stem cells. Cell 2008; 132: 1049-1061.
42. Morosetti R, Mirabella M, Gliubizzi C et al: Isolation and characterization of mesoangioblasts from facioscapulohumeral muscular dystrophy muscle biopsies. Stem Cells 2007; 25: 3173-3182.
43. Barro M, Carnac G, Flavier S, Mercier J, Vassetzky Y, Laoudj-Chenivesse D: Myoblasts from affected and non affected FSHD muscles exhibit morphological differentiation defects. J Cell Mol Med 2008, published online 24 May 2009, DOI 10.1111/j.1582-4934.2008.00368.x.